Pier 88 Investment Partners LLC Neurocrine Biosciences Inc Transaction History
Pier 88 Investment Partners LLC
- $75.6 Million
- Q4 2024
A detailed history of Pier 88 Investment Partners LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 4,690 shares of NBIX stock, worth $519,417. This represents 0.85% of its overall portfolio holdings.
Number of Shares
4,690
Previous 3,090
51.78%
Holding current value
$519,417
Previous $355,000
80.28%
% of portfolio
0.85%
Previous 0.47%
Shares
4 transactions
Others Institutions Holding NBIX
# of Institutions
656Shares Held
96.6MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.57 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.12 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$542 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$334 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$281 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...